Sanofi (SNY) Cash from Investing Activities (2019 - 2026)
Sanofi's Cash from Investing Activities history spans 7 years, with the latest figure at -$2.7 billion for Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 226.73% to -$2.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $4.9 billion, a 152.93% increase, with the full-year FY2025 number at -$2.8 billion, up 39.52% from a year prior.
- Cash from Investing Activities hit -$2.7 billion in Q1 2026 for Sanofi, up from -$2.8 billion in the prior quarter.
- Over the last five years, Cash from Investing Activities for SNY hit a ceiling of $10.8 billion in Q2 2025 and a floor of -$4.7 billion in Q4 2024.
- Historically, Cash from Investing Activities has averaged -$541.5 million across 3 years, with a median of -$1.7 billion in 2025.
- Biggest five-year swings in Cash from Investing Activities: soared 428.48% in 2025 and later tumbled 226.73% in 2026.
- Tracing SNY's Cash from Investing Activities over 3 years: stood at -$4.7 billion in 2024, then soared by 39.52% to -$2.8 billion in 2025, then rose by 6.37% to -$2.7 billion in 2026.
- Business Quant data shows Cash from Investing Activities for SNY at -$2.7 billion in Q1 2026, -$2.8 billion in Q4 2025, and -$369.4 million in Q3 2025.